IL-5-Deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses

Immunity

Volumn 4, Issue 1, 1996, Pages 15-24

  Kopf, Manfred ^a,d   Brombacher, Frank ^a   Hodgkin, Philip D ^b   Ramsay, Alistair J ^b   Milbourne, Elizabeth A ^c   Dai, Wen J ^a   Ovington, Karen S ^c   Behm, Carolyn A ^c   Köhler, Georges ^a   Young, Ian G ^c   Matthaei, Klaus I ^c  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEVELOPMENT; EOSINOPHILIA; GENE TARGETING; HELMINTHIASIS; HOST RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 13344277358     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80294-0     Document Type: Article

References (44)

1. Beagley, K.W., Eldridge, J.H., Kiyono, H., Everson, M.P., Koopman, W.J., Honjo, T., and McGhee, J.R. (1988). Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J. Immunol. 141, 2035-2042.
2. Boulay, J.L., and Paul, W.E. (1992). The interleukin-4 family of lymphokines. Curr. Opin. Immunol. 4, 294-298.
3. Campbell, H.D., Tucker, W.Q., Hort, Y., Martinson, M.E., Mayo, G., Clutterbuck, E.J., Sanderson, C.J., and Young, I.G. (1987). Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc. Natl. Acad. Sci. USA 84, 6629-6633.
4. Campbell, H.D., Sanderson, C.J., Wang, Y., Hort, Y., Martinson, M.E., Tucker, W.Q., Stellwagen, A., Strath, M., and Young, I.G. (1988). Isolation, structure and expression of cDNA and genomic clones for murine eosinophil differentiation factor: comparison with other eosinophilopoietic lymphokines and identity with interleukin-5. Eur. J. Biochem. 174, 345-352.
5. Coffman, R.L., Seymour, B.W., Hudak, S., Jackson, J., and Rennick, D. (1989a). Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245, 308-310.
6. Coffman, R.L., Lebman, D.A., and Shrader, B. (1989b). Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170, 1039-1044.
7. Corrigan, C.J., and Kay, A.B. (1992). T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13, 501-507.
8. Dent, L.A., Strath, M., Mellor, A.L., and Sanderson, C.J. (1990). Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 172, 1425-31.
9. Dranoff, G., Crawford, A.D., Sadelain, M., Ream, B., Rashid, A., Bronson, R.T., Dickersin, G.R., Bachurski, C.J., Mark, E.L., Whitsett, J.A., and Mulligan, R.C. (1994). Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264, 713-716.
10. Finkelman, F.D., Pearce, E.J., Urban, J.J., and Sher, A. (1991). Regulation and biological function of helminth-induced cytokine responses. Immunol. Today 12, 62-66.
11. Hardy, R.R., and Hayakawa, K. (1994). CD5 B cells, a fetal B cell lineage. Adv. Immunol. 55, 297-339.
12. Ishida, H., Hastings, R., Kearney, J., and Howard, M. (1992). Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175, 1213-1220.
13. Johnson, G.R., Nicholas, W.L., Metcalf, D., McKenzie, I.F., and Mitchell, G.F. (1979). Peritoneal cell population of mice infected with Mesocestoides corti as a source of eosinophils. Int. Arch. Allergy Appl. Immunol. 59, 315-322.
14. Jones, P.D., and Ada, G.L. (1986). Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection. J. Virol. 60, 614-619.
15. Kantor, A., Stall, A.M., Adams, S., Herzenberg, L.A., and Herzenberg, L.A. (1992). Differential development of progenitor activity for three B-cell lineages. Proc. Natl. Acad. Sci. USA 89, 3320-3324.
16. Karupiah, G., Coupar, B.E., Andrew, M.E., Boyle, D.B., Phillips, S.M., Mullbacher, A., Blanden, R.V., and Ramshaw, I.A. (1990). Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J. Immunol. 144, 290-298.
17. Kearney, J.F., Bartels, J., Hamilton, A.M., Lehuen, A., Solvason, N., and Vakil, M. (1992). Development and function of the early B cell repertoire. Int. Rev. Immunol. 8, 247-257.
18. Kinashi, T., Harada, N., Severinson, E., Tanabe, T., Sideras, P., Konishi, M., Azuma, C., Tominaga, A., Bergstedt, L.S., Takahashi, M., Matsuda, F., Yaoita, Y., Takatsu, K., and Honjo, T. (1986). Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324, 70-73.
19. Kocks, C., and Rajewsky, K. (1989). Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways. Annu. Rev. Immunol. 7, 537-559.
20. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M.C., Bluethmann, H., and Kohler, G. (1993). Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248.
21. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
22. Ledermann, B., and Burki, K. (1991). Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp. Cell Res. 197, 254-258.
23. Mandler, R., Chu, C.C., Paul, W.E., Max, E.E., and Snapper, C.M. (1993). Interleukin 5 induces S mu-S gamma 1 DNA rearrangement in B cells activated with dextran-anti-IgD antibodies and interleukin 4: a three component model for Ig class switching. J. Exp. Med. 178, 1577-1586.
24. Mansour, S.L., Thomas, K.R., and Capecchi, M.R. (1988). Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352.
25. Miyajima, A., Mui, A.F., Ogorochi, T., and Sakamaki, K. (1993). Receptors for granulocyte-macrophage-colony stimulating factor, interleukin-3, and interleukin-5. Blood 82, 1960-1974.
26. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65, 55-63.
27. Murray, P.D., McKenzie, D.T., Swain, S.L., and Kagnoff, M.F. (1987). Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J. Immunol. 139, 2669-2674.
28. IL3 receptor-deficient mice are normal. Immunity 2, 211-222.
29. Nitschke, L., Kopf, M., and Lamers, M.C. (1993). Quick nested PCR screening of ES cell clones for gene targeting events. Biotechniques 14, 914-916.
30. Pockley, A.G., and Montgomery, P.C. (1991). In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses. Immunology 73, 19-23.
31. Ramsay, A.J., and Kohonen Corish, M. (1993). Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur. J. Immunol. 23, 3141-3145.
32. Sanderson, C.J. (1992). Interleukin-5, eosinophils, and disease. Blood 79, 3101-3109.
33. Sanderson, C.J. (1994). Interleukin-5. In The Cytokine Handbook, A.W. Thomson, ed. (London: Academic Press, Limited), pp. 127-44.
34. Sanderson, C.J., Strath, M., Mudway, I., and Dent, L.A. (1993). Transgenic experiment with interleukin 5. In Eosinophils: Immunological and Clinical Aspects, G.J. Gleich and A.B. Kay, eds. (New York: Marcel Dekker, Incorporated), pp. 335-351.
35. Stanley, E., Lieschke, G.J., Grail, D., Metcalf, D., Hodgson, G., Gall, J.A., Maher, D.W., Cebon, J., Sinickas, V., and Dunn, A.R. (1994). Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91, 5592-5596.
36. Takahashi, T., Yamaguchi, N., Mita, S., Yamaguchi, Y., Suda, T., Tominaga, A., Kikuchi, Y., Miura, Y., and Takatsu, K. (1990). Structural comparison of murine T-cell (B151K12)-derived T-cell-replacing factor (IL-5) with rIL-5: dimer formation is essential for the expression of biological activity. Mol. Immunol. 27, 911-920.
37. Takatsu, K., Kikuchi, Y., Takahashi, T., Honjo, T., Matsumoto, M., Harada, N., Yamaguchi, N., and Tominaga, A. (1987). Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 84, 4234-4238.
38. Tchernitchin, A., Roorijck, J., Tchernitchin, X., Vandenhende, J., and Galand, F. (1974). Dramatic early increase in uterine eosinophils after oestrogen administration. Nature 248, 142-143.
39. Thomas, K.R., and Capecchi, M.R. (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
40. Tominaga, A., Takaki, S., Koyama, N., Katoh, S., Matsumoto, R., Migita, M., Hitoshi, Y., Hosoya, Y., Yamauchi, S., Kanai, Y., Miyazaki, J.I., Usuku, C., Yamamura, K.I., and Takatsu, K. (1991).Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173, 429-437.
41. Vaux, D.L., Lalor, P.A., Cory, S., and Johnson, G.R. (1990). In vivo expression of interleukin 5 induces an eosinophilia and expanded Ly-1 B lineage populations. Int. Immunol. 2, 965-971.
42. Warren, D.J., and Moore, M.A. (1988). Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells. J. Immunol. 140, 94-99.
43. Wetzel, G.D. (1989). Interleukin 5 regulation of peritoneal Ly-1 B lymphocyte proliferation, differentiation and autoantibody secretion. Eur. J. Immunol. 19, 1701-1707.
44. Yokota, T., Coffman, R.L., Hagiwara, H., Rennick, D.M., Takebe, Y., Yokota, K., Gemmell, L., Shrader, B., Yang, G., Meyerson, P., Luh, J., Hoy, P., Pene, J., Briere, F., Spits, H., Banchereau, J., DeVries, J., Lee, F.D., Arai, N., and Arai, K.I. (1987). Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5. Proc. Natl. Acad. Sci. USA 84, 7388-7392.